Waddell & Associates »

Royalty Pharma shares owned by Waddell & Associates

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Waddell & Associates from 13F filings

Historical chart of Waddell & Associates investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Waddell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Waddell & Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $205k 4.3k 47.97

More positions owned by Waddell & Associates

FedEx Corporation (FDX)
Global X Fds Us Infr Dev Etf (PAVE)
Pacer Fds Tr Globl Cash Etf (GCOW)
State Str Spdr S&p Midcap 40 Utser1 S&pdcrp (MDY)
Schwab Strategic Tr Fundamental Us S (FNDA)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Global X Fds Adaptive Us (AUSF)
Schwab Strategic Tr 1000 Index Etf (SCHK)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Direxion Shares Etf Trust Nasdaq 100 Eq Wt (QQQE)
Abrdn Fds Emerging Mkts Di (AGEM)
Apple (AAPL)
NVIDIA Corporation (NVDA)

View all positions for Waddell & Associates

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
FMR
BlackRock
Baillie Gifford & Co
Adage Capital Partners GP
Swedbank AB
State Street Corporation
Vanguard Group
Capital World Investors
Geode Capital Management
Caledonia
Victory Capital Management
Vanguard Capital Management
Northern Trust

View all funds holding Royalty Pharma